Form 8-K - Current report:
SEC Accession No. 0001558370-23-003572
Filing Date
2023-03-13
Accepted
2023-03-13 16:05:25
Documents
14
Period of Report
2023-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20230313x8k.htm   iXBRL 8-K 35421
2 EX-99.1 omer-20230313xex99d1.htm EX-99.1 246319
3 GRAPHIC omer-20230313xex99d1001.jpg GRAPHIC 5215
  Complete submission text file 0001558370-23-003572.txt   427422

Data Files

Seq Description Document Type Size
4 EX-101.SCH omer-20230313.xsd EX-101.SCH 3354
5 EX-101.LAB omer-20230313_lab.xml EX-101.LAB 15361
6 EX-101.PRE omer-20230313_pre.xml EX-101.PRE 10392
8 EXTRACTED XBRL INSTANCE DOCUMENT omer-20230313x8k_htm.xml XML 4664
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 23727308
SIC: 2834 Pharmaceutical Preparations